All filters
Slidesets
Co-infection of HTLV-1 permits HIV-1 direct infection of female genital epithelium in vitro despite antiretroviral therapy: Implications for HIV-1 vaginal transmission - Y. Tang
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Early transmission steps - Thomas Hope, PhD
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Safety and pharmacokinetics of quick dissolving polymeric vaginal films delivering antiretroviral combinations for pre-exposure - P. Srinivasan
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Pre-Exposure Prophylaxis Modality Preferences among Men who Have Sex with Men - E. Hall
Presented at:
International Workshop on HIV Transmission 2015
Slidesets
Approved Regimens for Non ‐Cirrhotic Patients - Graham Foster, FRCP, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Approved Regimens for Cirrhotic Patients - Marina Berenguer
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Panel Debate - Rafael Esteban, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Next Generation Regimens - Joost Drenth, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Liver Cancer - Massimo Colombo, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Decompensated Cirrhosis - Thomas Berg, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
08_sarrazin
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
09_Arends
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
10_Sarrazin
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Viral Co‐Infection - Mark Nelson, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
11_Zeuzem
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in the US - Fred Poordad, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Poland - Robert Flisiak, MD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Germany - Heiner Wedemeyer, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Holland - Rob de Knegt, MD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Spain - Maria Buti, MD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Resistance Case and Preventing Resistance - Stéphane Chevaliez, PharmD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
German Hepatitis C Resistance Registry - Christophe Sarrazin, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
The Toronto Declaration - Where are we now? - Jordan Feld, MD, MPH
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Hepatitis C Vaccines: Are we making progress? - Christopher M. Walker, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015